Sakata Y - Search Results

1

[Clinical evaluation of sulpiride against nausea and vomiting during cancer chemotherapy compared with domperidone--envelope method].

Sakata Y, Suzuki H, Satoh T, Kawatsu S, Tanabe K, Okamoto K, Takagi S, Komatsu Y, Kawakami K, Yoshida Y. Sakata Y, et al. Gan To Kagaku Ryoho. 1986 Jul;13(7):2415-8. Gan To Kagaku Ryoho. 1986. PMID: 3729495 Japanese.

2

[Phase II study of sustained released granules of tegafur (SF-SP) on inoperable or recurrent gastric cancer].

Sakata Y, Yoshida Y. Sakata Y, et al. Gan To Kagaku Ryoho. 1985 May;12(5):1068-72. Gan To Kagaku Ryoho. 1985. PMID: 3922308 Japanese.

3

[MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].

Sakata Y, Yoshida Y, Komatsu Y, Sugawara K, Nishimura S, Kikuchi K. Sakata Y, et al. Gan To Kagaku Ryoho. 1982 Jan;9(1):109-15. Gan To Kagaku Ryoho. 1982. PMID: 6820875 Japanese.

4

[Preventive effect of TJ-14, a kampo (Chinese herb) medicine, on diarrhea induced by irinotecan hydrochloride (CPT-11)].

Sakata Y, Suzuki H, Kamataki T. Sakata Y, et al. Gan To Kagaku Ryoho. 1994 Jul;21(8):1241-4. Gan To Kagaku Ryoho. 1994. PMID: 8031168 Japanese.

5

[Chemotherapy for pancreatic cancer].

Sakata Y, Takemori H, Suzuki H. Sakata Y, et al. Gan To Kagaku Ryoho. 1996 Oct;23(12):1647-50. Gan To Kagaku Ryoho. 1996. PMID: 8886035 Review. Japanese.

6

Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432 (MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancer.

Sakata Y, Komatsu Y, Takagi S, Saitoh S, Itoh T, Suzuki H, Tsushima K, Sasaki D, Yoshida Y. Sakata Y, et al. Cancer Chemother Pharmacol. 1989;23 Suppl:S9-12. doi: 10.1007/BF00647230. Cancer Chemother Pharmacol. 1989. PMID: 2647315 Clinical Trial.

7

[Phase II study of epirubicin in inoperable or recurrent gastric cancer].

Sakata Y, Yoshida Y. Sakata Y, et al. Gan To Kagaku Ryoho. 1986 May;13(5):1887-92. Gan To Kagaku Ryoho. 1986. PMID: 3458431 Clinical Trial. Japanese.

8

[Randomized controlled study of sequential methotrexate and 5-fluorouracil therapy with or without 5'-deoxy-5-fluorouridine against advanced gastrointestinal cancer. Hirosaki Cooperative Study Group for Cancer Chemotherapy].

Yamada Y, Tsushima K, Sakata Y, Saito S, Ito T, Sugimoto N, Ogasawara H, Tamura Y, Moriya N, Komatsu Y, et al. Yamada Y, et al. Among authors: sakata y. Gan To Kagaku Ryoho. 1994 Jul;21(8):1187-92. Gan To Kagaku Ryoho. 1994. PMID: 8031160 Clinical Trial. Japanese.

9

[Sequential methotrexate/5-fluorouracil therapy with 5'-deoxy-5-fluorouridine against advanced gastric cancer: comparison between bolus injection and drip infusion of 5-fluorouracil administration. Hirosaki Cooperative Study Group for Cancer Chemotherapy].

Yamada Y, Tsushima K, Sakata Y, Saito S, Ito T, Sugimoto N, Ogasawara H, Tamura Y, Moriya N, Komatsu Y, et al. Yamada Y, et al. Among authors: sakata y. Gan To Kagaku Ryoho. 1994 Jun;21(7):1029-32. Gan To Kagaku Ryoho. 1994. PMID: 8210253 Clinical Trial. Japanese.

10

Effect of combination of 5-fluorouracil, epirubicin and mitomycin C (FEM) on advanced gastric carcinoma.

Itoh T, Sakata Y, Tamura Y, Furukohori N, Saitoh S, Suzuki H, Tsushima K, Munakata A, Yoshida Y, Takagi S, et al. Itoh T, et al. Among authors: sakata y. Nihon Gan Chiryo Gakkai Shi. 1989 Aug 20;24(8):1551-6. Nihon Gan Chiryo Gakkai Shi. 1989. PMID: 2509606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,182 results

Search Page

Filters